Evidence map›Paper›PMID 42635437›Full record

ArticlemSystems2026

Integrative microbiome-methylome analysis links bacterial taxa to colorectal cancer histological subtypes.

Ángel Escudero-Jiménez, Jorge Galán-Ros, Francisco Huertas-López, Andrea Pérez-Sarabia, Diogo Ribeiro, Fátima Postigo-Corrales, Ana Albaladejo-González, María Isabel Díaz-López, María Dolores López-Abellán, José García-Rodríguez and 11 more

Abstract read
In one paragraph

Article in mSystems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ángel Escudero-Jiménez *Department of Microbiology and Parasitology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
Jorge Galán-Ros *Servicio de Microbiología y Parasitología, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Francisco Huertas-LópezMarbyt-Smart Solutions for Biotechnology S. L., Murcia, Spain.
Andrea Pérez-SarabiaGroup of Genetics, Molecular Pathology and Rare Diseases. Universidad Católica de Murcia (UCAM), Guadalupe, Spain.
Diogo RibeiroGroup of Genetics, Molecular Pathology and Rare Diseases. Universidad Católica de Murcia (UCAM), Guadalupe, Spain.
Fátima Postigo-CorralesGroup of Molecular Pathology and Pharmacogenetics, Instituto Murciano de Investigación Biosanitaria, Hospital General Universitario Santa Lucía, Cartagena, Spain.
Ana Albaladejo-GonzálezGroup of Genetics, Molecular Pathology and Rare Diseases. Universidad Católica de Murcia (UCAM), Guadalupe, Spain.
María Isabel Díaz-LópezGroup of Molecular Pathology and Pharmacogenetics, Instituto Murciano de Investigación Biosanitaria, Hospital General Universitario Santa Lucía, Cartagena, Spain.
María Dolores López-AbellánGroup of Molecular Pathology and Pharmacogenetics, Instituto Murciano de Investigación Biosanitaria, Hospital General Universitario Santa Lucía, Cartagena, Spain.
José García-RodríguezGroup of Molecular Pathology and Pharmacogenetics, Instituto Murciano de Investigación Biosanitaria, Hospital General Universitario Santa Lucía, Cartagena, Spain.
María Asunción Beltrán-VidelaGroup of Molecular Pathology and Pharmacogenetics, Instituto Murciano de Investigación Biosanitaria, Hospital General Universitario Santa Lucía, Cartagena, Spain.
Ana Belén ArroyoGroup of Molecular Pathology and Pharmacogenetics, Instituto Murciano de Investigación Biosanitaria, Hospital General Universitario Santa Lucía, Cartagena, Spain.
Ana María Hurtado LópezGroup of Genetics, Molecular Pathology and Rare Diseases. Universidad Católica de Murcia (UCAM), Guadalupe, Spain.
Ana Tapia-AbellánGroup of Molecular Pathology and Pharmacogenetics, Instituto Murciano de Investigación Biosanitaria, Hospital General Universitario Santa Lucía, Cartagena, Spain.
Rubén Corral San MiguelGroup of Molecular Pathology and Pharmacogenetics, Instituto Murciano de Investigación Biosanitaria, Hospital General Universitario Santa Lucía, Cartagena, Spain.
Edith Rodríguez-BraunGroup of Molecular Pathology and Pharmacogenetics, Instituto Murciano de Investigación Biosanitaria, Hospital General Universitario Santa Lucía, Cartagena, Spain.
Eduardo FeliciangeliGroup of Molecular Pathology and Pharmacogenetics, Instituto Murciano de Investigación Biosanitaria, Hospital General Universitario Santa Lucía, Cartagena, Spain.
Alberto Sánchez-EspinosaGroup of Molecular Pathology and Pharmacogenetics, Instituto Murciano de Investigación Biosanitaria, Hospital General Universitario Santa Lucía, Cartagena, Spain.
Ana ConesaGenomics of Gene Expression Lab, Institute of Integrative Systems Biology, Spanish National Research Council (CSIC-UV) Catedràtic Agustín Escardino Benlloch, Paterna, Spain.
Ginés Luengo-GilGroup of Molecular Pathology and Pharmacogenetics, Instituto Murciano de Investigación Biosanitaria, Hospital General Universitario Santa Lucía, Cartagena, Spain.ORCID 0000-0001-9940-0415
Pablo Conesa-ZamoraGroup of Molecular Pathology and Pharmacogenetics, Instituto Murciano de Investigación Biosanitaria, Hospital General Universitario Santa Lucía, Cartagena, Spain.ORCID 0000-0003-0190-3044

Funding

Agencia Estatal de Investigación RYC2022-037702-IAgencia Estatal de Investigación RYC2023-043193-IFundación Española de Trombosis y Hemostasia Justo Aznar postdoctoral fellowshipHorizon 2020 Framework Programme REVERT (GA848098)Instituto de Salud Carlos III PI23/00601
6 · The paper itself

Abstract

Colorectal cancer (CRC) arises through distinct molecular and histological routes that may be shaped by interactions between the mucosa-associated microbiota and host epigenetic regulation. We analyzed paired tumor and adjacent non-tumor colorectal mucosa from CRC patients stratified by histological subtype (conventional vs serrated-pathway groups). Microbiota composition was profiled by Illumina sequencing, and host DNA methylation was assessed using genome-wide CpG arrays with targeted validation. Alpha diversity showed modest tumor-non-tumor differences, with variation by anatomical location driven by distal tumors. Differential abundance testing identified tumor-associated genera, and linear discriminant modeling highlighted taxa with high discriminatory power, including

Indexed as

BacteriaColorectal NeoplasmsDNA MethylationEpigenomeGastrointestinal MicrobiomeMicrobiotaEpigenesis, GeneticFemaleHumanscolorectal cancermethylationmicrobiome

Identifiers

PMID42635437
PMCPMC13595989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.